NCT Number: NCT00258453
Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma
RATIONALE: Collecting information on how craniopharyngioma is diagnosed and treated may help doctors predict a patient's response to treatment and help plan the best treatment. It may also help identify the intermediate- and long-term effects of treatment.
PURPOSE: This clinical trial is collecting information on diagnosis, treatment, and quality of life of young patients who are undergoing surgery for craniopharyngioma.
Looking for future studies?
Notify MeKey information
Conditions
Age range
Up to 18 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Krankenhaus Dornbirn, Dornbirn, Austria
About this study
OBJECTIVES:
Primary
- Identify all applied therapy strategies in pediatric patients with craniopharyngioma.
- Correlate relapse status with different therapy strategies/modality in these patients.
- Determine the health status (i.e., ophthalmologic, neuropediatric, and endocrine findings) and the health-related quality of life of these patients after treatment.
Secondary
- Determine the incidence of craniopharyngioma in pediatric patients.
- Identify quality control measures for diagnosis and therapy in these patients.
- Improve long-term care through a standardized follow-up program in these patients.
- Determine the efficacy of endocrine substitution for postoperative hypopituitarism in these patients.
- Identify risk factors for developing obesity and correlate the neurotransmitter concentration of leptin and neuropeptide Y in cerebral spinal fluid, serum, and craniopharyngioma cystic fluid with the likelihood of developing obesity in these patients.
- Determine the incidence and extent of eating disorders in these patients.
OUTLINE: This is a multicenter study.
Patients undergo neurologic, endocrine, and ophthalmologic tests and anthropometric diagnostic measurements. Patients then undergo 1 of the following surgical procedures: total resection; incomplete, subtotal, or partial resection; biopsy; or cyst pressure release. Patients whose tumor relapses may undergo a second resection and/or radiotherapy.
Quality of life is assessed at baseline and then periodically thereafter.
After surgery, patients are followed periodically.
PROJECTED ACCRUAL: A total of 120 patients will be accrued for this study.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS:
- Diagnosis of primary craniopharyngioma by MRI and CT scan (initial diagnosis)
- Patients with only cystic sellar or parasellar malformation (e.g., Rathke pouch cysts or suprasellar cysts) are allowed but will undergo observation only
PATIENT CHARACTERISTICS:
Performance status
- Not specified
Life expectancy
- Not specified
Hematopoietic
- Not specified
Hepatic
- Not specified
Renal
- Not specified
PRIOR CONCURRENT THERAPY: Not specified
Treatment and study plan
Physiologic Testing
OtherBiopsy
ProcedureComputed Tomography
Procedureconventional surgery
ProcedureMagnetic Resonance Imaging
Proceduremanagement of therapy complications
Procedurepsychosocial assessment and care
Procedurequality-of-life assessment
Procedureradiation therapy
RadiationSponsors and collaborators
Lead sponsor
German Society for Pediatric Oncology and Hematology GPOH gGmbH
Other
Registry information
Official study title
Prospective, Multi-Center Survey Study of Children and Adolescents With Craniopharyngioma
Important dates
- Study start
- 2001
- Primary completion
- 2007
- Study completion
- 2009
- First posted
- Nov 24, 2005
- Registry last updated
- Aug 2, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Donepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the Brain
NCT00452868
Astrocytoma, Brain Diseases
Boston, Massachusetts, United States
View Trial DetailsProton Beam Radiation Therapy in Treating Young Patients Who Have Undergone Biopsy or Surgery for Medulloblastoma or Pineoblastoma
NCT00105560
Brain and Central Nervous System Tumors, Central Nervous System Neoplasms
Boston, Massachusetts, United States
View Trial DetailsModafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor
NCT01381718
Brain and Central Nervous System Tumors, Central Nervous System Neoplasms
Birmingham, Alabama, United States
View Trial DetailsIrinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid Tumors
NCT00389584
Brain Diseases, Brain Neoplasms
Sacramento, California, United States
View Trial Details